![Barbara Withers](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Barbara Withers
Chief Tech/Sci/R&D Officer at OCUPHIRE PHARMA, INC.
Network origin in Barbara Withers first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Barbara Withers via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Washington University in St. Louis | College/University | Masters Business Admin | |
F. Hoffmann-La Roche Ltd.
![]() F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Citigroup Global Markets, Inc. (Broker)
![]() Citigroup Global Markets, Inc. (Broker) Investment Banks/BrokersFinance Citigroup Global Markets, Inc. (Broker) (CGMI-Broker) is the broker/dealer division of Citigroup Global Markets, Inc., an investment bank headquartered in New York City with additional offices across the US. The firm was founded in 2004 and is a subsidiary of Citigroup Financial Products, Inc., ultimately held by Citigroup, Inc. (NYSE: C). CGMI-Broker covers all market capitalizations of the major global indices and provides macro and quantitative analysis of global markets and sector trends. Their core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis. | Investment Banks/Brokers | Analyst-Equity | |
Mesa Verde Ventures LLC
![]() Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures LLC (Mesa Verde Ventures) is a venture capital firm founded in 2006. The firm is headquartered in San Diego, California. | Investment Managers | Private Equity Investor | |
RetroSense Therapeutics LLC
![]() RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | Medical Specialties | Director/Board Member Chief Executive Officer | |
Aerpio Therapeutics, Inc.
![]() Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Kalyra Pharmaceuticals, Inc.
![]() Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Immusoft Corp.
![]() Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | Medical/Nursing Services | Corporate Officer/Principal Chief Executive Officer | |
University of Pennsylvania | College/University | Undergraduate Degree | |
Barclays Capital, Inc.
![]() Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Investment Banks/Brokers | Corporate Officer/Principal | |
Florida Institute of Technology, Inc. | College/University | Graduate Degree | |
Kansas State University | College/University | Doctorate Degree | |
University of California San Diego | College/University | Undergraduate Degree | |
Vanderbilt University Medical Center
![]() Vanderbilt University Medical Center Hospital/Nursing ManagementHealth Services Vanderbilt University Medical Center operates as a academic medical center. It provides patient care, research, and biomedical education services. The company is headquartered in Nashville, TN. | Hospital/Nursing Management | Corporate Officer/Principal | |
selectION, Inc.
![]() selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
Compendia Bioscience, Inc.
![]() Compendia Bioscience, Inc. Information Technology ServicesTechnology Services Compendia Bioscience, Inc. provides information solutions for oncology drug discovery. The company was founded by Daniel D. Rhodes and Arul Chinnaiyan in February 2006 and is headquartered in Canton, MI. | Information Technology Services | Founder | |
David Geffen School of Medicine | College/University | Doctorate Degree | |
HEALIOS K.K. | Pharmaceuticals: Major | Director/Board Member | |
Kelley School of Business | College/University | Masters Business Admin | |
The Leonard N Stern School of Business | College/University | Masters Business Admin | |
Vanderbilt University School of Medicine | College/University | Doctorate Degree | |
Oncternal Oncology, Inc.
![]() Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
JOURNEY MEDICAL CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
Novartis Institutes of Biomedical Research
![]() Novartis Institutes of Biomedical Research BiotechnologyHealth Technology Novartis Institutes of Biomedical Research operates a pharmaceutical research organization. The private company is based in Emeryville. | Biotechnology | Corporate Officer/Principal | |
OcuSub, Inc.
![]() OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO | |
KODIAK SCIENCES INC. | Biotechnology | Corporate Officer/Principal | |
jCyte, Inc.
![]() jCyte, Inc. Medical/Nursing ServicesHealth Services jCyte, Inc. engages in the provision of retinal therapies. Its therapy focuses with retinitis pigmentosa, and retinal progenitor cells. The company was founded by Terry O?Neal, Henry Klassen and Jing Yang in 2012 and is headquartered in Newport Beach, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Insilico Medicine Cayman TopCo
![]() Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Director of Finance/CFO | |
ZENTALIS PHARMACEUTICALS, INC. | Biotechnology | Founder | |
Ainsworth Bioconsulting LLC | Founder | ||
Midwest Vision Partners LLC
![]() Midwest Vision Partners LLC Medical/Nursing ServicesHealth Services Midwest Vision Partners LLC is a company that aims to become the leading provider of eyecare in the United States through collaboration and excellence. The company is based in Chicago, IL and has subsidiaries in the United States. The company supports eyecare professionals with operational best practices and support services to create a platform that provides the highest standards of patient care and attracts the best physicians. The company was founded in 2019 by Joseph E. Giles, and Jorge Lopez has been the CEO of the company since 2019. | Medical/Nursing Services | President | |
ISCEV | Corporate Officer/Principal | ||
Genevivo LLC | Chief Executive Officer | ||
Opus Genetics, Inc.
![]() Opus Genetics, Inc. BiotechnologyHealth Technology Opus Genetics, Inc. is a gene therapy company that focuses on treating inherited retinal diseases. The company is based in Raleigh, NC, and leverages knowledge of the best science and the expertise of pioneers in ocular gene therapy to transparently drive transformative treatments to patients. The company has a unique model and purpose, and is backed by Foundation Fighting Blindness's venture arm, the RD Fund. Opus Genetics has wholly owned programs in numerous orphan retinal diseases, and its AAV-based gene therapy portfolio tackles some of the most neglected forms of inherited blindness while creating novel orphan manufacturing scale and efficiencies. The company was founded in 2021 by Benjamin R. Yerxa, Peter L. Ginsberg, Jason D. Menzo, Jean Bennett, Russell Kelley, Jean Bennett. Benjamin R. Yerxa has been the CEO since 2021. | Biotechnology | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Ray Therapeutics, Inc.
![]() Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Founder | |
Pepose Vision Institute
![]() Pepose Vision Institute Hospital/Nursing ManagementHealth Services Pepose Vision Institute provides LASIK surgery and dry eye treatment services. The private company is based in Chesterfield, MO. The company was founded by Jay S. Pepose. | Hospital/Nursing Management | Founder |
Statistics
International
United States | 42 |
Switzerland | 2 |
Japan | 2 |
Hong Kong | 2 |
Germany | 2 |
Sectoral
Health Technology | 19 |
Consumer Services | 10 |
Finance | 6 |
Health Services | 6 |
Commercial Services | 4 |
Operational
Corporate Officer/Principal | 41 |
Director/Board Member | 37 |
Founder | 19 |
Chairman | 19 |
Undergraduate Degree | 13 |
Most connected contacts
Insiders | |
---|---|
James Manuso | 30 |
Cam Gallagher | 24 |
Susan Benton | 15 |
Richard Rodgers | 13 |
Joseph Schachle | 11 |
Nirav Jhaveri | 10 |
Jay Pepose | 10 |
Sean Ainsworth | 9 |
George Magrath | 8 |
Ash Jayagopal | 8 |
Mitchell Brigell | 6 |
Bernhard Hoffmann | 6 |
Drey Coleman | 4 |
Erik Sims | 4 |
Amy Rabourn | 3 |
- Stock Market
- Insiders
- Barbara Withers
- Company connections